Jules A. Maltz - Nov 28, 2022 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role: 10%+ Owner
Signature: /s/ Tracy Hogan, Attorney-In-Fact for Jules A. Maltz
Stock symbol: HIMS
Transactions as of: Nov 28, 2022
Transactions value $: $0
Form type: 4
Date filed: 11/30/2022, 03:20 PM
Previous filing: Sep 19, 2022
Next filing: Dec 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Ownership	Footnotes
transaction	HIMS	Class A Common Stock	Other	-14.7K	-44.38%	18.4K	Nov 28, 2022	Direct	F1
transaction	HIMS	Class A Common Stock	Other	+7.35K		7.35K	Nov 28, 2022	Held by Institutional Venture Management XV, LLC	F1, F2
transaction	HIMS	Class A Common Stock	Other	+7.35K		7.35K	Nov 28, 2022	Held by Institutional Venture Management XVI, LLC	F1, F2
holding	HIMS	Class A Common Stock				125K	Nov 28, 2022	Held by Jules Maltz and Kelly Greenwood Fam Tr UA 07/31/2018
holding	HIMS	Class A Common Stock				54K	Nov 28, 2022	Held by Institutional Venture Partners XV Executive Fund, L.P.	F2
holding	HIMS	Class A Common Stock				10.1M	Nov 28, 2022	Held by Institutional Venture Partners XV, L.P.	F2
holding	HIMS	Class A Common Stock				10.2M	Nov 28, 2022	Held by Institutional Venture Partners XVI, L.P.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the transfer of shares received by the Reporting Person upon the settlement of restricted stock units ("RSUs") that the Reporting Person received pursuant to the Issuer's non-employee director compensation policy. Pursuant to a series of Director Compensation Assignment Agreements, the Reporting Person has agreed to assign the beneficial interest in any equity awards granted to him for his service as director of the Issuer to Institutional Venture Management XV, LLC ("IVM XV") and Institutional Venture Management XVI, LLC ("IVM XVI").
F2	Mr. Maltz is a managing director of IVM XV, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and IVM XVI, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVM XV, IVM XVI, IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.

Content

Represents the transfer of shares received by the Reporting Person upon the settlement of restricted stock units ("RSUs") that the Reporting Person received pursuant to the Issuer's non-employee director compensation policy. Pursuant to a series of Director Compensation Assignment Agreements, the Reporting Person has agreed to assign the beneficial interest in any equity awards granted to him for his service as director of the Issuer to Institutional Venture Management XV, LLC ("IVM XV") and Institutional Venture Management XVI, LLC ("IVM XVI").

Mr. Maltz is a managing director of IVM XV, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and IVM XVI, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVM XV, IVM XVI, IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.